QLS-111-FDC | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

16,891 results for “QLS-111-FDC”

Trials

View all 6307 →

Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension

64 participants · First posted Jan 21, 2026

Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients

36 participants · First posted Feb 8, 2024

Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients

63 participants · First posted Aug 30, 2023

Drugs

View all 3532 →

QLS-111

QLS-101

Buruli FDC

Organizations

View all 61 →

FDC LIMITED

India

FDC India

India

KILANI MOHAMED MAHREZ

France

News

View all 6991 →

Qlaris Bio Develops Novel Fixed-Dose Combination Therapy Targeting Unaddressed Component of Glaucoma Treatment

Qlaris Bio Initiates Phase II Trial for Novel Glaucoma Therapy QLS-111 in South Korea

Qlaris Reports Positive Phase II Results for QLS-111 in Reducing Intraocular Pressure

Page 1 of 1690